ask="8.25"
ask_size="400"
average_daily_volume="52510"
bid="5.50"
bid_size="500"
book_value="-19.19"
change="-0.23"
change_from_200_day_moving_average="-0.07"
change_from_50_day_moving_average="0.08"
change_from_52_week_high="-30.85"
change_From_52_week_low="1.28"
change_in_percent="-3.03%"
close="7.37"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-8.04"
ebitda="-18.31M"
eps_estimate_current_year="-1.07"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-1.41"
ex_dividend_date="N/A"
float_shares="832000"
high="7.76"
high_52_weeks="38.22"
last_trade_date="1/18/2017"
last_trade_price="7.37"
last_trade_size="147"
last_trade_time="4:00pm"
low="7.19"
low_52_weeks="6.09"
market_capitalization="17.96M"
moving_average_200_day="7.44"
moving_average_50_day="7.29"
name="KalVista Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="10.64"
open="7.70"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-0.92%"
percent_change_from_50_day_moving_average="+1.11%"
percent_change_from_52_week_high="-80.72%"
percent_change_from_52_week_low="+21.02%"
previous_close="7.60"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="10.45"
revenue="1.77M"
shares_outstanding="2437000"
short_ratio="0.43"
stock_exchange="NGM"
symbol="KALV"
volume="27968"
weeks_range_52="6.09 - 38.22"
